Abstract Background and Aim To study the change in serum alpha fetoprotein (AFP) of
patients with recurrent hepatocellular carcinoma (HCC) after curative resection and to …

Background Preoperative α-fetoprotein (AFP) level levels may help select patients with
hepatocellular carcinoma (HCC) for surgery. The objective of the current study was to …

Background. The role of serum α-fetoprotein (AFP) as a marker for treatment response in
patients with hepatocellular carcinoma (HCC) receiving systemic therapy is poorly defined …

Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

Background Alpha-fetoprotein (AFP) is a well-identified biomarker in hepatocellular
carcinoma (HCC). However, only limited AFP-related studies have evaluated its early …

Background Although many studies have confirmed the prognostic value of preoperative
alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma (HCC), the association …

Purpose There are limitations in using radiologic evaluation to assess the treatment
outcome of patients with hepatocellular carcinoma (HCC). The use of serial α-fetoprotein …

Importance Serum α-fetoprotein (AFP) is a biomarker for hepatocellular carcinomas (HCCs)
associated with a more aggressive tumor phenotype and inferior outcomes after a liver …

Background Milan criteria (MC) represent the most commonly adopted criteria for the
selection of patients with hepatocellular carcinoma (HCC) waiting for liver transplantation …

Combined immune checkpoint inhibitors (ICIs) along with tyrosine kinase inhibitors (TKIs)
and locoregional therapies have been used increasingly to treat hepatocellular carcinoma …